96 studies
Cannabis and Cancer Research
Studies on cannabis for cancer symptoms such as nausea, pain and appetite, and on cannabinoids in the lab. Lab results are not treatments.
Latest Cancer studies
Preclinical CBD findings in cisplatin-resistant head and neck cancer
A lab-made degrader lowered CB1 levels and altered cancer-cell behavior
A novel cannabinoid boosts tamoxifen effects in cell and mouse models
CBC-derived compound 9 inhibits prostate cancer cells in laboratory tests
Israeli registry study finds sex differences in cannabis use and reported…
Survey finds similar cannabis use among rural and urban cancer patients
Two cases show stentless care was feasible, but cannabis causation is unproven
Cancer lab findings have not established cannabinoids as disease-modifying…
CBD–epirubicin carrier reduced ovarian cancer cell viability in vitro
Hemp stem extract countered BPA estrogen signaling in cells
Turmeric-cannabis extract shows laboratory anti-inflammatory activity
Pilot trial links higher THC doses with anxiety and insomnia improvement
Review contrasts hemp’s promise with tobacco’s enduring health risks
EFSA says the CBD-rich extract’s safety cannot be established
Cell-line study finds borate-cannabinoid responses vary by tumor model
Cannabinoid-drug interactions vary across brain tumor cell lines
Young cancer survivors describe cannabis access and care gaps
Cancer survivors with poorer mental health were more likely to use cannabis
Could the body’s cannabis system help protect weakened muscles?
Wheat cover crops may raise hemp disease and toxin risks
CBD reshapes prostate cancer cells and boosts drug effects
Cannabis testing finds hidden mold toxins in unregulated flowers
Smarter CBD delivery could overcome major treatment barriers
Cannabinoids weakened carboplatin effects in ovarian cancer cells
Why young cancer survivors blur medical and recreational use
How obesity, gut microbes, and cannabinoid biology may shape cancer
Cancer patients report different benefits from CBD and THC
A neuroimmune cancer regimen is linked to longer survival
Could cannabinoids reshape melanoma treatment through the microbiome?
Minor cannabinoids boost glioblastoma drug effects in the lab
Cannabinoid inflammation control may trade healing for immunity
Cannabinoids show cancer promise, but clinical proof remains limited
Cannabinoids disrupt bile duct cancer cells in early lab study
French study examines early-adult cannabis use and seminoma risk
Cannabis and cigarettes together threaten fetal lung development
Cancer patients with severe symptoms turn to cannabis for relief
Cannabis shows no liver damage risk in advanced cancer patients
Cannabinoids and melatonin could cut cancer drug toxicity by 75%
CBD boosts paclitaxel against lung cancer in preclinical tests
Cancer survivors and doctors disagree on cannabis risks
Why cancer patients stop using medical cannabis
CBD rewires cancer cell metabolism through lipid restructuring
How CBD may fit into the skin’s defense against UV damage
Cannabinoids fail to reduce opioid use in cancer pain
CBD may boost cancer immunity by altering tumor cells' immune invisibility
New CBD compound shows promise for safer skin pigmentation control
CBD reduces inflammation in breast cancer cells without toxicity
Hemp readily absorbs toxic elements—urgent need for safety testing standards
Explore More
Other research topics
Every study on the site, grouped by what it measured.
Know your high. Then remember it.
High IQ keeps the record: what you bought, how it hit, what to buy again.
High IQ: Cannabis Journal for iPhone opens to everyone soon.
Follow along
Strain drops, terpene explainers, and the myths Professor High keeps killing.